News

CURRENT EVENTS

With Biocorp being acquired by Novo Nordisk in October 2023, Mallya is now part of a broad portfolio of innovative connected devices. Stay tuned for Mallya’s next launches in various countries around the world!

...

Mallya exhibited at ATTD

The ATTD conference took place from March 6th to 9th in Florence, Italy. This event provided the team with the...

Mallya addresses various therapeutic areas

Initially created for disposable insulin injection pens, Mallya is now available for people using injection pens for growth hormone treatment....

Testimonies

Terabun-san

Terabun-san

"It has become an important partner in my daily management of diabetes."

Ines, 26

Ines, 26

DT1

“My only regret is that I didn’t discover Mallya sooner.“

Mélanie, 29

Mélanie, 29

DIABÈTE GESTA

“This new medical device does most of the work for me.“

Virginie, 29

Virginie, 29

DT1

“I almost regret not using an insulin pen anymore.“

Serge, 62

Serge, 62

DT2

“It’s less restrictive being diabetic since I’ve been using it. »

Laura, 24

Laura, 24

DT1

“I really like the device.“

Ilenia, 35

Ilenia, 35

DT1

“Everything is really simple and intuitive."

Adriana, 28

Adriana, 28

DT1

“What a great idea!“

Jorge , 40

Jorge , 40

DT1

“I’ve been won over by this connected device.“

Fermer
Il semblerait que la langue du site soit différente de la langue de votre navigateur.
Langue conseillée : flag
Langues disponibles :

Το ιατροτεχνολογικό προϊόν Mallya δεν είναι ακόμη διαθέσιμο στην αγορά στην Ελλάδα.